William Desmarais, Chief Business Officer at TScan Therapeutics, Inc. (TCRX), bought 2,500 shares at $9.08 ($23K) on 2021-08-27, disclosed to the SEC on 2021-08-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.